InvestorsHub Logo

NJ1982

02/23/16 4:12 PM

#72525 RE: Steve43 #72524

"Folks what it boils down to is a choice . You can either do total DD and research on BIEL its line of products its line of distributors and the approvals around the world Dr's statements videos explaining the tech involved or you can choose a one liner about Pink Sheets."

It doesn't have to be one or the other, it can be both. Clearly BIEL is onto something with their products, but that is not the only requirement for success, and they could fail for a ton of real reasons related to the SEC mess, lack of funding, rejection from FDA, poor supply chain, Capitol costs, etc, etc

How many other pink sheet companies have been successful? Very few if any, but with that said BIEL has more traction and sales than almost all other pinks.

It seems like both sides are extremely polarized. Where are the posters who see the potential and the risk?

RVC

02/24/16 9:49 AM

#72536 RE: Steve43 #72524

Boils-downto-SEC-has-provided-clear-concise-DD
See: http://www.sec.gov/litigation/admin/2016/33-10036.pdf
SEC has completed initial DD and acted upon those findings.
Subsequent action will be taken as those cited in the filing are given time to refute.
IMO This stock is a black-hole for any investor monies unless looking for a PR induced speculation bounce of 10-20%
Musical chair game, just try not getting caught holding the bag once SEC takes next "logical" steps.